The value of quantitative patient preferences in regulatory benefit-risk assessment

Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of...

Descripción completa

Detalles Bibliográficos
Autores principales: Egbrink, Mart oude, IJzerman, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865769/
https://www.ncbi.nlm.nih.gov/pubmed/27226836
http://dx.doi.org/10.3402/jmahp.v2.22761
_version_ 1782431833015713792
author Egbrink, Mart oude
IJzerman, Maarten
author_facet Egbrink, Mart oude
IJzerman, Maarten
author_sort Egbrink, Mart oude
collection PubMed
description Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.
format Online
Article
Text
id pubmed-4865769
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-48657692016-05-25 The value of quantitative patient preferences in regulatory benefit-risk assessment Egbrink, Mart oude IJzerman, Maarten J Mark Access Health Policy Short Communication Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues. Co-Action Publishing 2014-04-01 /pmc/articles/PMC4865769/ /pubmed/27226836 http://dx.doi.org/10.3402/jmahp.v2.22761 Text en © 2014 Mart oude Egbrink and Maarten IJzerman http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
spellingShingle Short Communication
Egbrink, Mart oude
IJzerman, Maarten
The value of quantitative patient preferences in regulatory benefit-risk assessment
title The value of quantitative patient preferences in regulatory benefit-risk assessment
title_full The value of quantitative patient preferences in regulatory benefit-risk assessment
title_fullStr The value of quantitative patient preferences in regulatory benefit-risk assessment
title_full_unstemmed The value of quantitative patient preferences in regulatory benefit-risk assessment
title_short The value of quantitative patient preferences in regulatory benefit-risk assessment
title_sort value of quantitative patient preferences in regulatory benefit-risk assessment
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865769/
https://www.ncbi.nlm.nih.gov/pubmed/27226836
http://dx.doi.org/10.3402/jmahp.v2.22761
work_keys_str_mv AT egbrinkmartoude thevalueofquantitativepatientpreferencesinregulatorybenefitriskassessment
AT ijzermanmaarten thevalueofquantitativepatientpreferencesinregulatorybenefitriskassessment
AT egbrinkmartoude valueofquantitativepatientpreferencesinregulatorybenefitriskassessment
AT ijzermanmaarten valueofquantitativepatientpreferencesinregulatorybenefitriskassessment

Ejemplares similares